The abortion rates in England and Wales were 15.9 per 1000 women in 2014, the rate slightly decreased among younger age groups and increased or remained stable among women over 25 years of age. Around 56% of abortion in England/Wales was of women over 25 years of age in 2014. In those, more than half women cancelling their pregnancies already had a child birth experience (with more the 40% of them had given birth a decade ago).
The majority of abortions performed were under 13 weeks of gestation, with termination procedures with abortion pills (carried out within 10 weeks) have steadily increased. Access to medication for aborting an early pregnancy has become a major factor in the increase of terminations within 10 weeks. Only a small number of women access abortive services after 20 weeks of gestation, (2% in 2014 and steadily decreasing); this may be due to late detection, sudden change in personal circumstances or health problems with wanted pregnancy. Even statistics show us that timely abortive procedure (within 10 weeks) is increasing and more people are aware with contraception education. Even so are the country’s policies on abortion meeting women’s needs?
The laws/policies regarding pregnancy cancellation have a come a long way since the 1967 Abortion act. Now women have a considerable control over their own reproductive system and are provided with safe/legal/in some cases funded services. Even so, the extent to orthodox laws and political influence/prejudice restrict the best usage of pregnancy cancellation/prevention methods is frustrating.
Development of pregnancy cancellation pills policies over time
Since it was approved, pregnancy termination drugs have a come a long way to be accepted as a primary method of ending a pregnancy that is within 10 weeks of gestation. Development of abortion pills, namely Mifepristone and Misoprostol has led the major transformation in abortion scene. This includes changes of abortive procedure that required trained professionals, surgery and hospital beds to a service that can be carried out by nurses/midwives and can be administered by women themselves.
Early medical abortion is increasingly being carried outside hospitals in clinics, in Europe and USA. Research on abortive drugs show that more flexibility can be introduced regarding it’s usage to create an effective, safe and easily accessible service. The recent U.S FDA ruling relaxed its policies concerning Mifepristone (the primary drug for termination). This amendment required changes in its labeling, dosage and regimen. The secondary drug, Misoprostol can now be administered at any place of the women’s choice.
Yet, in Britain the law is interpreted in a way that women cannot even hold a possibility of taking the secondary abortive drug misoprostol at home. It requires mandatory visit to the clinics and adjusting time (of ingesting the pill) as per the service provider’s schedule than the women’s requirement. Other problems include – fetal anomaly pregnancy cancellation denial and lack of abortive services in remote areas.
Underlying the above concerns about abortion are questions regarding its political issues, clinic practice, ethical debates and medical training. There is an existent gap between the needs/ expectations of women seeking abortion pills and reality of it, which these policies need to amend.
The majority of abortions performed were under 13 weeks of gestation, with termination procedures with abortion pills (carried out within 10 weeks) have steadily increased. Access to medication for aborting an early pregnancy has become a major factor in the increase of terminations within 10 weeks. Only a small number of women access abortive services after 20 weeks of gestation, (2% in 2014 and steadily decreasing); this may be due to late detection, sudden change in personal circumstances or health problems with wanted pregnancy. Even statistics show us that timely abortive procedure (within 10 weeks) is increasing and more people are aware with contraception education. Even so are the country’s policies on abortion meeting women’s needs?
The laws/policies regarding pregnancy cancellation have a come a long way since the 1967 Abortion act. Now women have a considerable control over their own reproductive system and are provided with safe/legal/in some cases funded services. Even so, the extent to orthodox laws and political influence/prejudice restrict the best usage of pregnancy cancellation/prevention methods is frustrating.
Development of pregnancy cancellation pills policies over time
Since it was approved, pregnancy termination drugs have a come a long way to be accepted as a primary method of ending a pregnancy that is within 10 weeks of gestation. Development of abortion pills, namely Mifepristone and Misoprostol has led the major transformation in abortion scene. This includes changes of abortive procedure that required trained professionals, surgery and hospital beds to a service that can be carried out by nurses/midwives and can be administered by women themselves.
Early medical abortion is increasingly being carried outside hospitals in clinics, in Europe and USA. Research on abortive drugs show that more flexibility can be introduced regarding it’s usage to create an effective, safe and easily accessible service. The recent U.S FDA ruling relaxed its policies concerning Mifepristone (the primary drug for termination). This amendment required changes in its labeling, dosage and regimen. The secondary drug, Misoprostol can now be administered at any place of the women’s choice.
Yet, in Britain the law is interpreted in a way that women cannot even hold a possibility of taking the secondary abortive drug misoprostol at home. It requires mandatory visit to the clinics and adjusting time (of ingesting the pill) as per the service provider’s schedule than the women’s requirement. Other problems include – fetal anomaly pregnancy cancellation denial and lack of abortive services in remote areas.
Underlying the above concerns about abortion are questions regarding its political issues, clinic practice, ethical debates and medical training. There is an existent gap between the needs/ expectations of women seeking abortion pills and reality of it, which these policies need to amend.